TC
TDOC icon

Truvestments Capital’s Teladoc Health TDOC Stock Holding History

Truvestments Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-212
Closed -$1.85K – 1117
2025
Q2 		$1.85K Sell
212
-10
-5% -$72 ﹤0.01% 848
2025
Q1 		$1.77K Sell
222
-118
-35% -$1.19K ﹤0.01% 879
2024
Q4 		$3.09K Sell
340
-27
-7% -$261 ﹤0.01% 769
2024
Q3 		$3.37K Buy
+367
New +$3.04K ﹤0.01% 732
2024
Q2 		– Sell
-682
Closed -$10.3K – 636
2024
Q1 		$10.3K Sell
682
-374
-35% -$6.79K ﹤0.01% 496
2023
Q4 		$22.8K Sell
1,056
-196
-16% -$3.62K 0.01% 423
2023
Q3 		$23.3K Sell
1,252
-73
-6% -$1.7K 0.01% 368
2023
Q2 		$33.5K Hold
1,325
– – 0.02% 325
2023
Q1 		$34.3K Sell
1,325
-885
-40% -$23.7K 0.02% 328
2022
Q4 		$52.3K Sell
2,210
-1,661
-43% -$44.8K 0.03% 296
2022
Q3 		$98K Sell
3,871
-23
-0.6% -$807 0.06% 204
2022
Q2 		$129K Buy
3,894
+77
+2% +$3.27K 0.08% 189
2022
Q1 		$275K Buy
3,817
+385
+11% +$27.7K 0.15% 131
2021
Q4 		$315K Sell
3,432
-25
-0.7% -$2.99K 0.16% 125
2021
Q3 		$438K Buy
3,457
+49
+1% +$7.13K 0.24% 102
2021
Q2 		$567K Sell
3,408
-208
-6% -$33.7K 0.31% 79
2021
Q1 		$657K Buy
3,616
+255
+8% +$59.1K 0.37% 72
2020
Q4 		$672K Buy
3,361
+2,130
+173% +$433K 0.47% 67
2020
Q3 		$269K Buy
1,231
+552
+81% +$117K 0.24% 114
2020
Q2 		$129K Sell
679
-557
-45% -$97.6K 0.13% 126
2020
Q1 		$191K Buy
+1,236
New +$144K 0.24% 92
2019
Q4 		– Sell
-1,165
Closed -$79K – 537
2019
Q3 		$79K Buy
+1,165
New +$76.7K 0.05% 198

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Truvestments Capital's TDOC Position: Q3 2025 in Review

Truvestments Capital sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 212 shares — an estimated $1.85K sold.

Truvestments Capital first reported a position in TDOC in Q3 2019 and held it in 22 quarters. The position peaked at $672K in Q4 2020. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Truvestments Capital reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Truvestments Capital sold 212 Teladoc Health shares in Q3 2025, an estimated $1.85K.
  • Truvestments Capital first reported a position in Teladoc Health in Q3 2019 and held it in 22 quarters.
  • Truvestments Capital's Teladoc Health position peaked at $672K in Q4 2020.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Truvestments Capital's 13F filing for Q3 2025, filed 14 Nov 2025.